Correlation Between Cytokines and Hepatic Histology in Patients Infected by HIV-1 and the Hepatitis-C Virus
NCT00499434 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 110
Last updated 2009-12-04
Summary
This study aims at correlating TNF-α, INF-γ, IL-2, IL-4, IL-10 and TGF-β values as dosed by ELISA and mRNA expression by real-time PCR with histopathological hepatic biopsy findings in individuals with HIV/HCV coinfection. This population will be divided into three groups (G1: with no HAART; G2: with detected HIV viral load (HIV VL); G3: with undetected HIV VL), which will be then compared to two control groups with monoinfection by HIV or by HCV, in addition to a third control group comprising normal blood donors.
Conditions
- Acquired Immune Deficiency Syndrome
- Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
- HIV Infections
Sponsors & Collaborators
-
UPECLIN HC FM Botucatu Unesp
lead OTHER
Principal Investigators
-
Alexandre N Barbosa, MD, MSc · UPECLIN HC FM Botucatu Unesp
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-08-31
- Primary Completion
- 2009-01-31
- Completion
- 2010-02-28
Countries
- Brazil
Study Locations
More Related Trials
-
Study of Populations at Risk of Developing Chronic Hepatitis Linked to Chronic Enteric Virus Infection in Patients With Primary Immunodeficiency and Secondary Humoral Deficiency
NCT06659588 ·Status: RECRUITING
-
Cell Bound Complement Activation Proteins as Markers of Liver Injury
NCT01025531 ·Status: WITHDRAWN
-
Specific Biomarkers of Immune-mediated Hepatitis Secondary to Immune Checkpoint Inhibitors
NCT06470997 ·Status: RECRUITING
-
Study of Clinical Features of Patients With Autoimmune Liver Disease Complicated With Covid-19 and the Immune Mechanism Affecting Prognosis
NCT06099626 ·Status: UNKNOWN
-
Autoimmune Hepatitis Study
NCT00286663 ·Status: TERMINATED
-
FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of Response to Antiviral Therapy
NCT00606528 ·Status: COMPLETED
-
Assessment of Endocan Serum Levels in Patients With Behcet Disease
NCT03853135 ·Status: COMPLETED
-
Study IL- 35 Level and Fibronectin Type Ⅲ Domain Containing Protein 5 \ Irsin (FNDC5 rs3480) Gene Variations in Chronic Hepatitis B.
NCT06023745 ·Status: UNKNOWN
-
FGL2/Fibroleukin and Hepatitis C Virus Recurrence Post Liver Transplantation
NCT00701272 ·Status: UNKNOWN
-
Patterns and Outcome of Autoimmune Related Liver Disease
NCT03898414 ·Status: COMPLETED
-
Dose Effect Relationship of MTX and IBD
NCT03531593 ·Status: COMPLETED
-
Intervention, Prognosis and Mechanism of Covid-19 Infection in Patients With Underlying Diseases
NCT05965843 ·Status: UNKNOWN
-
Gene Polymorphism of IL17 and IL 23
NCT04948515 ·Status: COMPLETED
-
Metabolic Associated Fatty Liver Disease in Patients With Chronic Glomerular Disease
NCT06691529 ·Status: NOT_YET_RECRUITING
-
Discrimination of DILI and AIH by Artificial Intelligence
NCT05532345 ·Status: COMPLETED
-
Identification and Verification of Neutrophil Extracellular Trap Net Related Markers in Acute-on-chronic Liver Failure
NCT05909319 ·Status: UNKNOWN
-
UDCA in the Treatment of COVID-19 Infection and Its Clinical Prognosis in Patients With Autoimmune Liver Disease
NCT05812612 ·Status: UNKNOWN
-
Effects of Direct Antiviral Agents on Hepatitis C Virus Arthropathy
NCT03226717 ·Status: UNKNOWN
-
Comparison of Inflammatory Profiles and Regenerative Potential in Alcoholic Liver Disease
NCT03773887 ·Status: RECRUITING ·Phase: NA
-
Liver Cirrhosis Patients With Invasive Pulmonary Aspergillosis: in Depth Understanding Clinical Host Risk Factors
NCT07238114 ·Status: ACTIVE_NOT_RECRUITING
-
Is Negativity of Autoantibodies a Marker of Severity in Auto-immune Hepatitis?
NCT06761209 ·Status: RECRUITING
-
Albumin Modifications as Early Biomarkers of Chronic Liver Diseases
NCT06318949 ·Status: RECRUITING ·Phase: NA
-
Role of USP35 in the Detection of Ferroptosis in Juvenile Autoimmune Hepatitis
NCT06896383 ·Status: NOT_YET_RECRUITING
-
Study of Lymphopenia as a Specific Biomarker or Prognostic Risk Factor for Disease Severity in Elderly Patients With COVID-19
NCT04800731 ·Status: COMPLETED
-
Are SARS-CoV-2 Specific Antibodies a Correlate for Protection?
NCT04469634 ·Status: COMPLETED ·Phase: NA